Lineage Cell Therapeutics
LCTX
#7576
Rank
HK$3.02 B
Marketcap
HK$13.15
Share price
-1.74%
Change (1 day)
181.68%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2025 (TTM): -HK$0.16 Billion

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are HK$10.81 Million. In 2024 the company made an earning of -HK$0.17 Billion, an increase over its 2023 earnings that were of -HK$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.16 Billion-5.14%
2024 -HK$0.17 Billion-13.16%
2023 -HK$0.2 Billion9.83%
2022 -HK$0.18 Billion-54.24%
2021 -HK$0.39 Billion86.07%
2020 -HK$0.21 Billion-31.97%
2019 -HK$0.31 Billion-5.42%
2018 -HK$0.32 Billion1.1%
2017 -HK$0.32 Billion-31.06%
2016 -HK$0.46 Billion-10.38%
2015 -HK$0.52 Billion29.69%
2014 -HK$0.4 Billion31.68%
2013 -HK$0.3 Billion
2011 -HK$0.15 Billion89.78%
2010 -HK$76.67 Million206.06%
2009 -HK$25.05 Million-0.58%
2008 -HK$25.2 Million164.89%
2007 -HK$9.52 Million-30.22%
2006 -HK$13.63 Million
2002 -HK$15.83 Million-41.04%
2001 -HK$26.85 Million-32.04%
2000 -HK$39.51 Million-11.85%
1999 -HK$44.82 Million
1997 -HK$28.79 Million12.12%
1996 -HK$25.68 Million106.25%
1995 -HK$12.45 Million-11.11%
1994 -HK$14.01 Million50%
1993 -HK$9.34 Million20%
1992 -HK$7.79 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-HK$1.16 Billion 627.71%๐Ÿ‡บ๐Ÿ‡ธ USA